Liver disease in pregnancy

American Journal of Gastroenterology

Volumn 99, Issue 12, 2004, Pages 2479-2488

  Benjaminov, Fabiana S ^a   Heathcote, Jenny ^b  

^a MEIR MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ALBUMIN; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; CHORIONIC GONADOTROPIN; CORTICOSTEROID; CORTICOTROPIN; CYCLOSPORIN; ESTROGEN; FOLLITROPIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HYDROCORTISONE; IMMUNOGLOBULIN; LUTEINIZING HORMONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROGESTERONE; PROSTACYCLIN; TACROLIMUS;

AUTOIMMUNE HEPATITIS; DELTA AGENT HEPATITIS; ECLAMPSIA; GALLSTONE; HELLP SYNDROME; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HUMAN; HYPEREMESIS GRAVIDARUM; INTRAHEPATIC CHOLESTASIS; LIVER ADENOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FATTY DEGENERATION; LIVER HEMATOMA; LIVER RUPTURE; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; VENOUS THROMBOEMBOLISM;

FEMALE; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 11144300741     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.30231.x     Document Type: Review

References (115)

1. Van Thiel DH, Gavaler JS. Pregnancy associated sex steroids and their effect on the liver. Semin Liver Dis 1987;7:1-7.
2. Elliot JR, O'Kell RT. Normal clinical chemical values for pregnant woman at term. Clin Chem 1971;17:156-7.
3. Valenzuela GJ, Munson LA, Tarbauox NM, et al. Time-dependent changes in bone, placental, intestinal and hepatic alkaline phosphatase activities in serum during human pregnancy. Clin Chem 1987;33:1801-6.
4. Bacq Y, Zarka O, Brechot JF, et al. Liver function tests in normal pregnancies: A prospective study of 103 pregnant women and 103 match controls. Hepatology 1996;23:1030-4.
5. Meade BW, Rosalki SB. Serum enzyme activity in normal pregnancy and the newborn. J Obstet Gynecol 1963;70:693-700.
6. Fairweather DVI, Loraine JA. Nausea and vomiting in pregnancy. Am J Gynecol 1968;102:135-73.
7. Wallstedt A, Riele CA, Sharer D, et al. Prevalence and characteristics of liver dysfunction in hyperemesis gravidarum (abstract). Clin Res 1990;38:970A.
8. Kuscu NK, Koyuncu F. Hyperemesis gravidarum: Current concepts and management. Postgrad Med 2002;78:76-9.
9. Robertson C, Millar H. Hyperamylasemia in bulimia nervosa and hyperemesis gravidarum. Int J Ear Disord 1999;26:223-7.
10. Fatum M, Abramob Y. Hyperemesis gravidarum: An updated review. Harefuah 2003;142(1):61-5.
11. Leylek OA, Cetin A, Toyaki M, et al. Hyperthyroidsm in hyperemesis gravidarum. Int J Gynecol Obstet 1996;55:33-7.
12. Hill JB, Yost NP, Wendel GD. Acute renal failure in association with severe hyperemesis gravidarum. Obstet Gynecol 2002;110(5 Pt 2):1119-21.
13. Tsang IS, Katz VL, Wells SD. Maternal and fetal outcome in hyperemesis gravidarum. Int J Gynecol Obstet 1996;55:231-235.
14. Cannogia I, Winter J, Lye SJ, et al. Oxygen and placental development during the first trimester: Implications for the pathophysiology of pre-eclampsia. Placenta 2000;21(SupplA):525-30.
15. Bussen S, Sutterlin M, Steck T. Plasma endothelin and big endothelin levels in women with severe pre-ecampsia or HELLP syndrome. Arch Gynecol Obstet 1999;262:113-9.
16. Walsh SW, Vaughan JE, Wang Y, et al. Placental isoprostane is significantly increased in pre-eclampsia. FASB J 2000;14:1289-96.
17. de LB I, Batini L, Simonelli M, et al. Increased HLA-DR homozygosity associated with pre-eclampsia. Hum Reprod 2000;15:1807-12.
18. Knox TA, Olans LB. Liver disease in pregnancy. N Engl J Med 1996;335(8):569-76.
19. Roltes DB, Ishak ICG. Liver disease in toxemia of pregnancy. Am J Gastroenterol 1986;81:1138-44.
20. Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-6.
21. Martin JN, Magann GF, Blake PG. Analysis of 454 pregnancies with severe pre-eclampsia/eclampsia and HELLP syndrome using 3-class system of classification. Am J Obstet Gynecol 1993;68:386-91.
22. Egerman RS, Sibai BM. HELLP syndrome. Clin Obstet Gynecol 1999;42:381-9.
23. Sibai BM. The HELLP syndrome, hemolysis, elevated liver enzymes and low platelets: Much ado about nothing? Am J Obstet Gynecol 1990;162:311-6.
24. Shehata N, Burrow RF, Kelton JG. Gestational thrombocytopenia. Clin Obstet Gynecol 1999;42:327-34.
25. Kem PC, Thompson SA, Liew ACS. Thrombocytopenia in the parturient. Anesthesia 2004;59:255-64.
26. Saphier CJ, Repke T. Hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome: A review of diagnosis and management. Semin Perinatal 1998;22(2):118-33.
27. Sibai BM, Ramadan MK, Chari RS, et al. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes and low platelets): Subsequent pregnancy outcome and long term prognosis. Am J Obstet Gynecol 1995;172:125-9.
28. Castro MA, Fassett MJ, Reynolds TB, et al. Reversible peripartum liver failure: A new perspective on the diagnosis, treatment and causes of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 1999;181:389-95.
29. Burroughs AK, Seong NH, Dojcinov DM, et al. Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med 1982;51:481-97.
30. Sims HF, Brackett JC, Treem WR, et al. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA 1995;92:841-45.
31. Yang Z, Yamada J, Zhao Y, et al. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancy complicated by liver disease. JAMA 2002;288:2163-6.
32. Ijlst L, Oostheim W, Ruiter JP, et al. Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Identification of two new mutations. J Inherit Metab Dis 1997;20:420-2.
33. Ibdah JA, Bennet MJ, Rinaldo P, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999;340:1723-31.
34. Treem WR, Rinaldo P, Hale DE, et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Hepatology 1994;14:339-45.
35. Bacq Y. Acute fatty liver of pregnancy. Seminars of perinatology 1998;22(2):134-40.
36. Rahman TM, Wendon J. Severe hepatic dysfunction in pregnancy. Q J Med 2002;95:343-57.
37. Bellig LL: Maternal acute fatty liver of pregnancy and associated risk for long chain hydroxyacyl CoA dehydrogenase deficiency in infants. Adv Neonatal Care 2004;4(1):26-32.
38. Ibdah JH, Zhao Y, Viola J, et al. Molecular prenatal diagnosis in families with fetal mitochondrial trifunctional protein mutations. J Pediatr 2001;138:396-9.
39. Henny P, Lim AE, Brummelkamp WH, et al. A review of the importance of acute multidisciplinary treatment following spontaneous rapture of the liver capsule during pregnancy. Surg Gynecol Obstet 1983;156:593-6.
40. Moen MD, Calinedo MJ, Marshall W, et al. Hepatic rupture in pregnancy associated with cocaine use. Obstet Gynecol 1993;82:687-9.
41. Ralaton SJ, Schwaitzberg SD. Liver hematoma and rupture in pregnancy. Semin Perinatal 1998;22(2):141-8.
42. Westengraard L. Spontaneous rupture of the liver in pregnancy. Acta Obstet Gynecol Scand 1980;59:559-61.
43. Reyes H. Review: Intrahepatic cholestasis. A puzzleing disorder of pregnancy. J Gastroenterol Hepatol 1997;12:211-6.
44. Mullally BA, Hansen WF. Intrahepatic cholestasis of pregnancy. Review of the literature. Obstet Gynecol Surv 2001;57(1):47-52.
45. Smith AJ, de Vree JML, Ottenhoff R, et al. Hepatocytes specific expression of the human MDR3 p-glycoprotein gene restores the biliary phosphatidycholine excretion absent in Mdr2 (-/-) mice. Hepatology 1998;28:530-6.
46. Jacquemin E, Cresteil D, Manouvrier S, et al. Heterogenous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999;353:210-1.
47. Meng L, Reyes H, Palma J, et al. Effects of Ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. J Hepatol 1997;27:1029-40.
48. Reyes H, Sjovall J. Bile acids and progesterone in intrahepatic cholestasis of pregnancy. Ann Med 2000;32:94-106.
49. Xie W, Radomiska-Pandya A, Shi Y, et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 2001;98:3375-80.
50. Bergasa VE, Jones EA. The pruritus of cholestasis: Potential pathogenic and therapeutic implications of opioids. Gastroenterology 1995;108:1582-8.
51. Rioswco AJ, Ivankovic MB, Manzur A, et al. Inrahepatic cholestasis of pregnancy: A retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994;170:890-5.
52. Kowdley KV. Ursodeoxycholic acid and therapy in hepatobilliary disease. Am J Med 2000;108:481-6.
53. Palma J, Reyes H, Ribalta J, et al. UDCA in the treatment of cholestasis of pregnancy: A randomized, double-blind study controlled with placebo. J Hepatol 1997;27:1022-8.
54. Heinonen S, Kivkinen P. Pregnancy outcome with intrahepatic cholestasis of pregnancy. Obstet Gynecol 1999;94:189-93.
55. Rustgi VK, Hoofnagle JH. Viral hepatitis during pregnancy. Semin Liver Dis 1987;7:40-6.
56. Melnick J. History and epidemiology of hepatitis A virus. J Infect Dis 1995;171(Suppl 1):S2.
57. Shapiro C, Coleman P, McQuillan G, et al. Epidemiology of hepatitis A: Seroepidemiology and risk groups in the USA. Vaccine 1992;10(Suppl 1):S59.
58. Magriples U. Hepatitis in pregnancy. Seminars in perinatology 1998;22(2):112-7.
59. Xu DZ, Van YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: A case-control study. J Med Virol 2002;671(1):20-6.
60. Beasley RP, Trepo C, Stevens CE, et al. e anigen and vertical transmission of hepatitis B antigen. Am J Epidemiol 1977;105:94-8.
61. Carman WF, Jacyna MR, Hadziyannis S, et al. Mutations preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989;2:588-91.
62. Hadziyannis SJ. Hepatitis Be antigen negative chronic hepatitis B: From clinical recognition to pathogenesis and treatment. Viral Hepat Rev 1995;1:7-36.
63. The Incident Investigation Teams. Transmission of hepatitis B to patients from four surgeons without hepatitis Be antigen. N Engl J Med 1997;336:178-84.
64. Beasley RP, Hwang LY, Lin CC, et al. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 1982;146:198-204.
65. Wong S, Chan LY, Yu V, et al. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol 1999;16(9):485-8.
66. CDC. Update: Recommendations to prevent Hepatitis B virus transmission-United States. MMWR 1995;44:574-5.
67. Hill JB, Sheffield JS, Kim MJ, et al. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002;99(6): 1049-52.
68. Bortolotti F, Resti M, Giacchino R, et al. Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children. J Pediatr 1998;133:378-81.
69. Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002;36:S106-13.
70. Jabeen T, Cannon B, Hogan J, et al. Pregnancy and pregnancy outcome in hepatitis C type 1b. Q J Med 2000;93:597-601.
71. Conte D, Franquelli M, Prati D, et al. Prevalence and clinical course of chronic hepatitis C virus infection and rate of HCV vertical transmission in a cohort of 12,250 pregnant women. Hepatology 2000;31:751-5.
72. Polywka S, Schroter M, Feucht HH, et al. Low risk of vertical transmission of hepatitis C by breast milk. Clin Infect Dis 1999;29:1327-9.
73. Ceci O, Margiotta M, Marello F, et al. High rate of spontaneous viral clearance in a cohort of vertical infected hepatitis C virus infants: What lies behind? J Hepatol 2001;35:687-8.
74. Ketzinel-Gilad M, Colodner SL, Hadary R, et al. Transient transmission of hepatitis C virus from mothers to newborns. Eur J Clin Microbiol Infect Dis 2000;19:267-74.
75. Kumar KM, Udumans S, Rana S, et al. Seroprevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001;100(1):9-15.
76. Singh S, Mohanty A, Joshi YK, et al. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 2003;70(1):37-9.
77. Cundy TF, Butler J, Pope RM, et al. Amenorrhea in women with non-alcoholic chronic liver disease. Gut 1991;32:202-6.
78. Heneghan MA, Norris SM, O'Grady JG, et al. Management and outcome of pregnancy in autoimmune hepatitis. Gut 2001;48:97-102.
79. Buchel E, Van Steenbergen W, Nevens F, et al. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol 2001;97:3160-5.
80. Stevens MM, Buckley JD, Mackay IR. Pregnancy in chronic active hepatitis. Q J Med 1979;192:519-31.
81. H2 phenomenon? Immunol Today 1993;14:353-6.
82. Wilder RL. Hormones, pregnancy and autoimmune diseases. Ann NY Acad Sci 1998;840;45-50.
83. Park-Wyllie L, Mazzotta P, Pastuszac A, et al. Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiologic studies. Teratology 2000;62(6):385-92.
84. Patel PA, Gold E, Utts J, et al. The association between gravity and primary biliary cirrhosis. Ann Epidemiol 2002;12(4):264-72.
85. Hempfling W, Dilger K, Beurs U. Systematic review: Ursodeoxycholic acid-adverse effects and drug interactions. Aliment Pharmacol Ther 2003;18:963-72.
86. Janczewska I, Olsson R, Hultcrantz R, et al. Pregnancy in patients with primary sclerosing cholangitis. Liver 1996;16(5):326-330.
87. Everson GT. Gastrointestinal motility in pregnancy. Gastroenterol Clin North Am 1992;21:751-76.
88. Kapicioglu S, Gurbuz S, Danalioglu A, et al. Measurement of gallbladder volume with ultrasonography in pregnant women. Can J Gastroenterol 2000;14(5):403-5.
89. Tierney S, Nakeeb A, Wong O, et al. Progesterone alters biliary flow dynamics. Ann Surg 1999;229(2):205-9.
90. Valdivieso V, Covarrubias C, Siegel P, et al. Pregnancy and cholelithiasis: Pathogenesis and natural course of gallstones diagnosed in early puerporium. Hepatology 1993;17:1-4.
91. Everson GT. Gallbladder function in gallstone disease. Gastroenterol Clin North Am 1991;20:85-110.
92. Maringhini A, Clambra M, Baccelliere P, et al. Biliary sludge and gallstones in pregnancy: Incidence, risk factors, and natural history. Ann Intern Med 1993;119:116-20.
93. Gilat T, Konikoff F. Pregnancy and the biliary tract. Can J Gastroenterol 2000;14(Suppl D):55D-59D.
94. Marighini A, Mareeno MP, Lanzarone F, et al. Sludge and stones in gallbladder after pregnancy. Prevalence and risk factors. J Hepatol 1987;5:218-23.
95. Prevention of venous thrombosis and pulmonary embolism. NIH Consensus Development. JAMA 1986;256(6):744-9.
96. Sellman JS, Holman RL. Thromoembolism during pregnancy. Postgrad Med 2000;108(4):71-84.
97. Clapp JF, Stepanchak W, Tomaselli J, et al. Portal vein blood flow-effects of pregnancy, gravity and exercise. Am J Obstet Gynecol 2000;183(1):167-72.
98. Denninger MH, Chait Y, Casadevall N, et al. Causes of portal or hepatic vein thrombosis in adults: The role of multiple concurrent factors. Hepatology 2000;31(3):587-91.
99. Russel MA, Craigo SD. Cirrhosis and portal hypertension in pregnancy. Semin Perinatol 1998;22(2):156-65.
100. Yip D, Baker A. Liver diseases and pregnancy. Clin Perinatol 1985;12(3):683-94.
101. Cheng Y. Pregnancy in liver cirrhosis and portal hypertension. Am J Obstet Gynecol 1977;127:b812-22.
102. Homburg R, Bayer L, Lurie B. Bleeding esophageal varices in pregnancy. J Repro Med 1988;33:784.
103. Hamilton M, Alcock R, Magis L, et al. Liver transplantation during pregnancy. Liver Trans Proc 1993;25:2967-8.
104. Barret J, Caldwell B. Association of portal hypertension and ruptured splenic artery aneurysm in pregnancy. Obstet Gynecol 1981;57:255-7.
105. Hill MA, Albert T, Zieske A, et al. Successful resection of multifocal hepatic adenoma during pregnancy. South Med J 1997;90(3):357-61.
106. Bis KA, Waxman G. Rupture of the liver associated with pregnancy: A review of the literature and report of two cases. Obstet Gynecol Surv 1976;31:763-73.
107. Terkivatan De Wilt, JHW, De Man RA, et al. Management of hepatocellular adenoma during pregnancy. Liver 2000;20:186-7.
108. Gianopoulos JG. Establishing the criteria for anasthesia and other precautions for surgery during pregnancy. Surg Clin North Am 1995;75:33-45.
109. Laifer SA, Guido R. Reproductive fonction and outcome of pregnancy after liver transplantation in women. Mayo Clin Proc 1995;70:388-94.
110. Beitinis IZ, Bayard F, Ances IG, et al. The transplacental passage of prednisone in pregnancy near term. J Perinatol 1972;81;936-45.
111. Casele HL, Laifer SA. Pregnancy after liver transplantation. Semin Perinatol 1998;22(2):149-55.
112. Ross WB, Richards T, Williams GL, et al. Cyclosporine and pregnancy. Transplantation 1988;45(6):1142.
113. Jain A, Venkateramanan R, Lever J, et al. FK 506 in pregnancy in liver transplant patients. Transplantation 1993;56:1588-9.
114. Armenti VT, Radomski JS, Moriz MJ, et al. Report from the national transplantation pregnancy registry (NTPR): Outcomes of pregnancy after transplantation. Clin Transpl 2001;97-105.
115. Casele HL, Woelkers DA, Laifer SA. Pregnancy after liver transplantation. Am J Obstet Gynecol 1997;176:S23.